Čájehuvvojit 1 - 8 oktiibuot 8 bohtosis ohcui ', ohcanáigi: 0,02s Aiddostahte ozu
  1. 1

    The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
  2. 2

    Imperial College London's saRNA Vaccine - COVAC1

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
  3. 3

    Human challenge trials for vaccines against COVID-19

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
  4. 4

    COVID-19 epidemiology and potential treatments follow up interview /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
  5. 5

    COVID-19 epidemiology and potential treatments follow up interview /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
  6. 6

    Human challenge trials for vaccines against COVID-19

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
  7. 7

    Imperial College London's saRNA Vaccine - COVAC1

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna
  8. 8

    The Oxford/AstraZeneca COVID-19 vaccine trial adverse patient event reports /

    Almmustuhtton 2020
    Viečča ollesdeavstta
    Series
    Elektrovnnalaš Jietna